title: Androgen deprivation therapy for localized and nonmetastatic prostate cancer: too much of a good thing?
authors.forename: Ramdev
authors.initials: R
authors.lastname: Konijeti
authors.forename: Adam S
authors.initials: AS
authors.lastname: Kibel
mesh_terms: D000726:Androgen Antagonists / Q000009:adverse effects*; D018931:Antineoplastic Agents, Hormonal / Q000009:adverse effects*; D006801:Humans; D008297:Male; D009376:Neoplasms, Hormone-Dependent / Q000628:therapy*; D009919:Orchiectomy / Q000009:adverse effects*; D058729:Peripheral Arterial Disease / Q000453:epidemiology*; D011471:Prostatic Neoplasms / Q000628:therapy*; D054556:Venous Thromboembolism / Q000453:epidemiology*
chemical_list: D000726:Androgen Antagonists; D018931:Antineoplastic Agents, Hormonal